Gregory Buncke, MD
Plastic and Reconstructive Surgery · San Francisco, CANPI 1396736633
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Axogen accounts for 87.7% of it on its own, with 36 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $543.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$92K
- Johnson & Johnson$10K
- Endo Pharmaceuticals Inc.$655
- Alafair Biosciences, Inc.$314
- Urgo Medical North America, LLC$276
- Smith+Nephew$238
- plus $2K from 31 others
Across 26 payments — averaging $4133.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axogen$107K
What the payments were for
- Consulting fees$43,86342%
- Speaking & faculty fees$47,32545%
- Travel & lodging$6,3316%
- Food & beverage$7,3527%
- Education$900%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 73 | $92,025 |
| Johnson & Johnson(2 entities) | 12 | $9,826 |
| Endo Pharmaceuticals Inc. | 23 | $655 |
| Alafair Biosciences, Inc. | 3 | $314 |
| Urgo Medical North America, LLC | 9 | $276 |
| Smith+Nephew | 7 | $238 |
| Electronic Waveform Lab, Inc. | 9 | $186 |
| Polarityte, Inc. | 5 | $144 |
| Biocircuit Technologies Inc | 2 | $111 |
| Orthofix Medical, Inc. | 4 | $103 |
| Baxter Healthcare | 3 | $98 |
| Bioventus LLC | 3 | $97 |
| Stryker(2 entities) | 3 | $95 |
| Integra Lifesciences Corporation | 4 | $93 |
| Checkpoint Surgical, Inc | 3 | $69 |
| Vertex | 2 | $63 |
| Access Pro Medical, LLC | 1 | $62 |
| Endo USA, Inc. | 2 | $53 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $49 |
| Pacira Pharmaceuticals Incorporated | 2 | $44 |
| Medela LLC | 2 | $35 |
| Mimedx Group, Inc. | 2 | $35 |
| AbbVie | 2 | $34 |
| Derma Sciences, Inc. | 1 | $31 |
| Acell, Inc. | 1 | $30 |
| Solventum Corporation | 1 | $29 |
| Tactile Systems Technology Inc | 1 | $28 |
| Mallinckrodt Enterprises LLC | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Acacia Pharma Inc | 2 | $18 |
| Polynovo North America LLC | 1 | $18 |
| Innovation Technologies Inc | 1 | $17 |
| Evolution Surgical, Inc | 1 | $16 |
| Ossur Americas, Inc. | 1 | $15 |
| Zimmer Biomet | 1 | $14 |
| Molnlycke Health Care US, LLC | 1 | $12 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$67,660
- AxoGuard Nerve Protector$54,458
- AxoGuard Nerve Connector$54,458
- AXOGUARD$4,250
- AXOGUARD HA+ NERVE PROTECTOR$2,929
- AxoGuard Nerve Cap$2,929
- XIAFLEX$300
- VersaWrap$296
How this compares
$104,983 in reported general payments places this provider in the 95th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $2,565 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in San Francisco
- Corey MaasSan Francisco$286K
- Charles LeeSan Francisco$200K
- David SieberSan Francisco$195K
- Thomas SatterwhiteSan Francisco$11K
- Mark SuskiThousand Oaks$294K
- Arian MowlaviLaguna Beach$250K
- David KulberLos Angeles$194K
- Matthew NykielUpland$181K
- Subhas GuptaLoma Linda$178K
- Jeffrey HammoudehLos Angeles$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.